The enrichment of Smc3wt/– centrocyte transcriptional signature in accelerated lymphomas induced by Smc3 haploinsufficiency, prompted us to explore whether these profiles are linked to clinical outcome DLBCL patients. The gene discussed is SMC3; the disease is lymphoma.